Kentucky Commission Adopts RCI Model Drug Rules: Paulick Report 4/18/17

By: Natalie Voss The Kentucky Horse Racing Commission voted unanimously Tuesday afternoon to accept model drug rules set by the Association for Racing Commissioners International. Dr. Mary Scollay, equine medical director for the commission, said the updates represented about a year's work and more than 175 individual edits to bring the state's rules in line

Kentucky Rescinds Dextrorphan Positives, But No Victory For Proponents Of Environmental Contamination: Paulick Report 2/23/17

By: Natalie Voss The Kentucky Horse Racing Commission agreed earlier this year to rescind three recent violations related to overages of dextrorphan, a metabolite of dextromethorphan. However, according to Dr. Mary Scollay, equine medical director for the commission, the dismissal shouldn't be seen as a victory by horsemen and veterinarians concerned about environmental contamination. The

Kentucky Rescinds Dextrophan Positives: Blood-Horse 2/21/17

By: Frank Angst Citing new research that suggests the metabolite of Dextromethorphan, Dextrorphan, can stay in a horse's system at a wider variance of time than previously realized, the Kentucky Horse Racing Commission earlier this year dropped sanctions in three cases where the metabolite was discovered. KHRC equine medical director Mary Scollay offered a presentation

With Eye Toward Uniformity, Kentucky Reviews Drug Rules: Blood-Horse 2/1/17

By: Frank Angst After an in-depth review of its racing medication rules relative to the Association of Racing Commissioners International’s recommendations, a Kentucky council is recommending penalty classification changes for a pair of medications. The Kentucky Equine Drug Research Council recommended Feb. 1 that the expectorant ambroxol (Ambril) be moved to a more severe penalty

Kentucky Drug Testing Lab Enjoys Expansion: Blood-Horse 11/30/16

By: Frank Angst While the focus of the expanded LGC Science facility in Lexington will be on testing human-use supplements, as opposed to the lab's equine drug testing, the additional expertise on such supplements could provide crossover benefit. Lexington political and business leaders attended a ribbon-cutting Nov. 30 to celebrate the expanded LGC facility. LGC is a

Kentucky Likely to Put Labs to the Test: Blood-Horse 10/29/16

By: Frank Angst The Kentucky Horse Racing Commission will likely run double-blind quality assurance testing on its lab after the state’s Equine Drug Research Council approved plans Oct. 28 to carry out such tests. The EDRC approved up to $16,000 from its Rapid Response fund to work with three lab horses at Kentucky Equine Research